• Lyazzat Kulembekova, David Hailey, Maksut Kulzhanov, Adlet Tabarov, Svetlin Georgiev, Magdalena Jaworzynska, Antoniya Yordanova Yanakieva, and Lyazzat Kosherbayeva.
• Health Policy and Management Department, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
• Patient Prefer Adher. 2024 Jan 1; 18: 100910151009-1015.

BackgroundIn recent years, involvement of healthcare stakeholders in health technology assessment (HTA) has been discussed as helping the inclusion of social values in the decision-making process. The aim of our research was to identify and compare details from Kazakhstan, Poland and Bulgaria on their stakeholders' involvement in the HTA process. Information was sought on their identification, responsibilities, and regulation.MethodsWe conducted a survey of seven types of stakeholders in the healthcare systems of Kazakhstan, Poland, and Bulgaria. They included patients and the public, providers, purchasers, payers, policy makers, product makers, and principal investigators. They were questioned on their involvement in the HTA process, and on the objectives of their participation.ResultsLevels of involvement of different kinds of stakeholder varied between countries, reflecting political and administrative developments. There was full or partial agreement on the objectives of stakeholder participation. All respondents agreed that representatives of the ministry of health should be involved in selection of stakeholders for HTA.ConclusionProgress has been made in the involvement of stakeholders, with interest in further development in all three countries.© 2024 Kulembekova et al.

5 keywords...

hide…